Interestingly, clinical studies demonstrated that the success of PD1/PD-L1 blockade by either anti-PD1 or anti-PD-L1 antibody has a positive correlation with PD-L1 expression levels in tumor cells62,77–79. Here, CD274 is linked to neoplasm.